81 results
Page 3 of 5
424B3
bcsghb121ljbqn27w16
22 Nov 13
Prospectus supplement
12:00am
8-K
EX-99.1
ybrflazr wcpt6ru
9 Sep 13
Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
12:00am
424B3
btd00fvxp4r5ggu70nas
5 Mar 13
Prospectus supplement
12:00am
8-K
EX-99.1
mmiuikbtfbsv lqv6
4 Mar 13
Cellceutix Signs with Leading Cancer Center For Licensing New Drug
12:00am
8-K
EX-99.1
26wn1
26 Dec 12
Cellceutix Comments on New York Times Article Heralding p53 Drugs as the New Age in Cancer Research
12:00am
8-K
EX-99.1
lbx3d85rh 89ovx2
10 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
fakbtubd2iq0
22 Jun 12
Cellceutix Approved By FDA to Proceed with Clinical Trials on Novel Cancer Drug
12:00am